Loading…
Enzymology Research Center, Inc. received an FDA Warning Letter on March 26, 2020, regarding drug products. Based on the limited metadata available, specific violation details cannot be determined as the subject line information is not provided. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata.